StonvexLoading…
StonvexStonvexStonvexCore line items from IIIV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $213.16M | $191.23M | $189.68M | $187.75M |
Operating Income | $3.78M | $4.36M | $-4.41M | $-23.14M |
Net Income | $17.87M | $113.34M | $-811.00K | $-17.10M |
EPS (Diluted) | $0.72 | $4.73 | $-0.07 | $-0.77 |
Total Assets | $638.41M | $730.67M | $884.42M | $770.31M |
Total Liabilities | $120.69M | $215.32M | $556.12M | $462.62M |
Cash & Equivalents | $66.67M | $86.53M | $3.10M | $3.49M |
Free Cash Flow OCF − CapEx | $3.75M | $45.45M | $32.97M | $41.49M |
Shares Outstanding | 34.19M | 33.88M | 33.25M | 22.25M |